-
1.
公开(公告)号:US20190083628A1
公开(公告)日:2019-03-21
申请号:US16079290
申请日:2017-02-21
Inventor: Tomohiro HAYASHIDA , Yohei HOASHI , Shin IJITSU , Yoshio NAKANO , Junji YAMAZAKI , Katsuhisa INOUE , Atsushi AIZAWA
IPC: A61K47/38 , A61K9/20 , A61K47/32 , A61K9/00 , A61K31/136
Abstract: Provided are pharmaceutical composition particles which are capable of achieving both of masking of an unpalatable taste and improvement in dissolution properties; an orally disintegrating tablet including the pharmaceutical composition particles; and a method for manufacturing the pharmaceutical composition particles. Each of the pharmaceutical composition particles includes: a core particle containing a water-soluble gelling swelling substance; an intermediate layer containing a drug and coating an outside of the core particle; and an outer layer containing a water-insoluble substance and coating an outside of the intermediate layer. In addition, the orally disintegrating tablet includes the above-described pharmaceutical composition particles.
-
公开(公告)号:US20200214985A1
公开(公告)日:2020-07-09
申请号:US16641014
申请日:2018-08-20
Inventor: Tomohiro HAYASHIDA , Yohei HOASHI , Shin IJITSU , Yoshio NAKANO , Junji YAMAZAKI , Katsuhisa INOUE , Atsushi AIZAWA
Abstract: Pharmaceutical composition particle capable of masking an unpalatable taste and improvement in dissolution properties, an orally disintegrating tablet containing the pharmaceutical composition particle, and a method for manufacturing a pharmaceutical composition particle. The pharmaceutical composition particle includes a core particle containing a drug and a water-soluble gelling swelling substance; and an outer layer which contains a water-insoluble substance and constitutes a coating provided on the outer side of the core particle. The method for manufacturing includes: pulverizing a water-soluble gelling swelling substance to have an average particle diameter of 15 μm or less; a core particle manufacturing step of mixing the water-soluble gelling swelling substance pulverized and a drug to manufacture a core particle; and an outer layer formation step of coating the core particle with a water-insoluble substance on the outer side of the core particle.
-
公开(公告)号:US20220218617A1
公开(公告)日:2022-07-14
申请号:US17605860
申请日:2020-04-21
Applicant: NIPRO CORPORATION
Inventor: Yoshio NAKANO , Tomohiro HAYASHIDA , Yohei HOASHI , Keisuke EDAMURA , Yuki ICHIKAWA
IPC: A61K9/28 , A61K31/352 , A61K9/20 , A61K31/137
Abstract: Problem to be Solved
Provided is a method for manufacturing a pharmaceutical preparation, which safely and simply enables uniformization of contents of a small amount of a drug.
[Solution]
The method for manufacturing the pharmaceutical preparation includes: using a liquid for dispensing, the liquid containing a drug; and a first application step of applying the drug to a surface of a tablet or a capsule by a dispensing method. In addition, a pharmaceutical preparation according to the present invention includes: a base; and a drug which is applied to a surface of the base by a dispensing method, and the base is a tablet or a capsule.-
公开(公告)号:US20190054029A1
公开(公告)日:2019-02-21
申请号:US16079288
申请日:2017-02-21
Inventor: Tomohiro HAYASHIDA , Yohei HOASHI , Shin IJITSU , Yoshio NAKANO , Junji YAMAZAKI , Katsuhisa INOUE , Atsushi AIZAWA
IPC: A61K9/20 , A61K9/00 , A61K31/137 , A61K47/32 , A61K47/38
Abstract: Provided are pharmaceutical composition particles which are capable of achieving both of masking of an unpalatable taste and improvement in dissolution properties; an orally disintegrating tablet including the pharmaceutical composition particles; and a method for manufacturing the pharmaceutical composition particles. Each of the pharmaceutical composition particles includes: a drug-containing core particle; an intermediate layer containing a gelling swelling substance and coating an outside of the core particle; and an outermost layer containing a water-insoluble substance and coating an outside of the intermediate layer. In addition, the method for manufacturing the pharmaceutical composition particles includes: a pulverization step of pulverizing the gelling swelling substance so as to have an average particle diameter of 15 μm or less; a suspension step of obtaining a suspension by suspending the gelling swelling substance pulverized at the pulverization step in an organic solvent; an intermediate layer formation step of forming an intermediate layer on an outside of a core particle by spraying the suspension obtained at the suspension step onto the core particle containing a drug; and an outer layer formation step of forming an outer layer by coating an outside of the intermediate layer with a water-insoluble substance.
-
公开(公告)号:US20170196816A1
公开(公告)日:2017-07-13
申请号:US15315449
申请日:2015-06-02
Applicant: NIPRO CORPORATION
Inventor: Yohei HOASHI , Shotaro IKUTA
CPC classification number: A61K9/2072 , A61J3/005 , A61J3/007 , A61K9/2813 , A61K9/2866 , A61K9/2886 , A61K9/2893 , A61K31/47 , A61K31/505 , A61K31/551 , A61K45/00
Abstract: A laser-printable tablet has: a tablet containing an optically unstable drug, a first cover layer that covers the tablet and contains a first color change-inducing oxide, and a second cover layer that covers the first cover layer and contains a second color change-inducing oxide, the concentration in which the second color change-inducing oxide is contained in the second cover layer being different from the concentration in which the first color change-inducing oxide is contained in the first cover layer.
-
-
-
-